Table 1. Baseline characteristics of propensity-score matched cohort of atrial fibrillation stratified by diabetes.
| Characteristic | Diabetes Mellitus | Overall (n=1818) | P-value | |
|---|---|---|---|---|
| NO (n=909) | YES (n=909) | |||
| Age, mean (SD) (in years) | 74.1 (12.2) | 74.0 (10.7) | 74.0(11.5) | .29 |
| Men | 512(56.3%) | 495 (54.5%) | 1007 (55.4%) | .42 |
| Body mass index (kg/m2) | 30.2 (7.7) | 30.2 (6.7) | 30.2 (7.2) | .22 |
| Heart rate (beats per min) | 109.3 (32.4) | 108.9(31.7) | 109.1 (32.0) | .86 |
| Systolic Blood pressure (mmHg) | 131.6(22.1) | 131.3(21.7) | 131.4(21.9) | .70 |
| Diastolic Blood pressure (mmHg) | 71.4(14.5) | 71.2(14.1) | 71.3(14.3) | .88 |
| Hypertension | 818(90.0%) | 818(90.0%) | 1636 (90.0%) | 1.00 |
| Dyslipidemia | 689 (75.8%) | 690(75.9%) | 1379 (75.9%) | .96 |
| Coronary Artery Disease | 591 (65.0%) | 570 (62.7%) | 1161 (63.9%) | .30 |
| Heart failure | 294 (32.3%) | 288(31.7%) | 582 (32.0%) | .76 |
| Prior Stroke | 179 (19.7%) | 201 (22.1%) | 380 (20.9%) | .20 |
| Peripheral Arterial Disease | 234(25.7%) | 231 (25.4%) | 465 (25.6%) | .87 |
| Smoker (past or present) | 290(31.9%) | 273 (30.0%) | 563(31.0%) | .39 |
| Chronic lung disease | 358 (39.4%) | 348 (38.3%) | 706 (38.8%) | .63 |
| Obstructive sleep apnea | 284(31.2%) | 270 (29.7%) | 554 (30.5%) | .47 |
| Chronic Renal Disease | 360 (39.6%) | 361 (39.7%) | 721 (39.7%) | .96 |
| Malignancy | 331 (36.4%) | 340 (37.4%) | 671 (36.9%) | .66 |
| White blood cell count (1000 per mm3) | 9.4 (5.4) | 9.5 (5.3) | 9.4 (5.3) | .57 |
| Glomerular filtration rate (ml/min/1.73m2) | 55.9 (26.3) | 55.9 (27.5) | 55.9 (26.9) | .97 |
| LV ejection fraction (%) | 53.8(15.1) | 53.7 (15.4) | 53.8(15.3) | .89 |
| Statins | 515(56.7%) | 523(57.5%) | 1038(57.1%) | .70 |
| Oral Anticoagulation (Warfarin or NOAC) | 482(53.0%) | 486(53.5%) | 968 (53.2%) | .85 |
| Beta-Blocker | 625(68.8%) | 635(69.9%) | 1260 (69.3%) | .61 |
| Calcium Channel-blocker | 452(49.7%) | 437(48.1%) | 889 (48.9%) | .48 |
| ACE-I or ARB | 581(63.9%) | 610(67.1%) | 1191 (65.5%) | .15 |
| Antiplatelets | 251(27.6%) | 237(26.1%) | 488 (26.8%) | .45 |
Represented as Number (percentage) or mean (standard deviation)
Abbreviations: LV: left ventricle; ACE-I: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker
Footnote: Dyslipidemia was defined as total cholesterol >200 mg/dl or low-density cholesterol levels >100 mg/dl or high-density cholesterol levels <60 mg/dl